The European Medicines Agency (EMA) said on Friday it had approved emergency use in the European Union of the anti-Covid pill from Merck, which has yet to receive full marketing authorization. Marlet.
Read alsoCovid-19: the European authority paves the way for the use of Merck's anti-Covid tablets
"The drug, which is currently not authorized in the EU, can be used to treat adults with Covid-19 who do not need supplemental oxygen and who are at increased risk of developing a severe form" of the disease, the EMA said in a statement.
